Business & Economics

Ado-trastuzumab emtansine Approved for the Treatment of Early Breast Cancer

In early May 2019, the United States Food and Drug Administration (FDA) approved ado-trastuzumab emtansine (Kadcyla®, Genentech/Roche; T-DM1) for...
Photo: Exhibition - Bird's Eye Overview. The 15th annual PEGS: The Essential Protein Engineering Summit brought more than 2,700 world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions to the Seaport World Trade Center in Boston, MA this past April 8-12, 2019, setting record-breaking attendance. Photo courtesy: CHI/PEGS

PEGS 2019: Using Economic Modelling In the ADC Manufacturing Supply Chain

Antibody-drug conjugates have become a strong and promising strategy for the treatment of cancer, and, potentially emerging in therapeutic...
Featured Image: Scientist in Biomedical Laboratory. Courtesy 2019 Fotolia. used with permission.

Femtogenix Signs License Agreement with Iksuda Therapeutics

Iksuda Therapeutics, formerly known as Glythera, confirmed that it has signed a licensing agreement with Femtogenix. The agreement gives...

Investment Company Cobepa Acquires BioAgilytix

BioAgilytix, a large molecule bioanalytical testing services, confirmed the agreement to be acquired by Cobepa S.A., a privately-held investment...
WuXi Biologics. 1,000 LX2 disposable bioreactors for perfusion processes.

Single-layer Film Bags vs. Multi-layer Film Bags Biopharmaceutical Manufacturing

Since the early 1970s, single-use, disposable plastic technology for the manufacturing of biopharmaceutical products according to the U.S. Food...